| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 72.86B | 71.85B | 61.56B | 58.80B | 54.34B | 41.44B |
| Gross Profit | 39.97B | 38.60B | 30.14B | 29.83B | 26.76B | 17.88B |
| EBITDA | 32.07B | 31.60B | 23.94B | 23.23B | 20.79B | 12.44B |
| Net Income | 18.62B | 19.24B | 15.22B | 15.02B | 13.35B | 6.94B |
Balance Sheet | ||||||
| Total Assets | 141.28B | 142.28B | 122.52B | 108.03B | 95.90B | 78.06B |
| Cash, Cash Equivalents and Short-Term Investments | 69.69B | 71.79B | 55.25B | 49.80B | 44.62B | 34.09B |
| Total Debt | 0.00 | 0.00 | 400.00M | 733.00M | 1.70B | 1.97B |
| Total Liabilities | 9.81B | 14.43B | 13.31B | 13.81B | 16.22B | 11.72B |
| Stockholders Equity | 131.47B | 127.85B | 109.20B | 94.22B | 79.68B | 66.34B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 15.37B | 5.97B | 6.95B | 11.02B | 5.18B |
| Operating Cash Flow | 0.00 | 25.35B | 17.22B | 15.65B | 14.76B | 10.71B |
| Investing Cash Flow | 0.00 | -7.68B | -10.81B | -8.76B | -3.52B | -5.38B |
| Financing Cash Flow | 0.00 | -1.51B | -1.36B | -1.88B | -1.13B | -801.92M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥811.08B | 26.71 | 13.15% | 0.23% | 2.66% | 7.90% | |
78 Outperform | ¥693.42B | 15.50 | 8.07% | 2.85% | 11.18% | -0.75% | |
74 Outperform | ¥7.69T | 59.16 | 8.95% | 1.88% | 2.88% | 28.76% | |
67 Neutral | ¥4.30T | 15.03 | ― | 1.41% | 7.73% | -1.93% | |
64 Neutral | ¥165.87B | 29.59 | 5.91% | 2.39% | -3.24% | -25.21% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
56 Neutral | ¥637.10B | 15.62 | ― | 2.57% | 4.81% | -49.43% |